84 related articles for article (PubMed ID: 24340465)
21. The effect of granulocyte colony stimulating factor in patients with leukopenia due to sepsis.
Bittner EW; Hartzog JM; Chendrasekhar A
W V Med J; 1995; 91(6):273. PubMed ID: 7502498
[TBL] [Abstract][Full Text] [Related]
22. G-CSF is a major component of colony-stimulating activity (CSA) in the plasma of patients with multiple myeloma after treatment with high-dose melphalan (HDM).
Joffe JK; Bell JB; Denham S; Adshead F; Millar JL; Millar BC
Exp Hematol; 1995 Apr; 23(4):376-82. PubMed ID: 7534716
[TBL] [Abstract][Full Text] [Related]
23. Dexamethasone pulse therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis.
Kardaun SH; Jonkman MF
Acta Derm Venereol; 2007; 87(2):144-8. PubMed ID: 17340021
[TBL] [Abstract][Full Text] [Related]
24. Toxic epidermal necrolysis treated with cyclosporin and granulocyte colony stimulating factor.
Jarrett P; Rademaker M; Havill J; Pullon H
Clin Exp Dermatol; 1997 May; 22(3):146-7. PubMed ID: 9425696
[TBL] [Abstract][Full Text] [Related]
25. Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure.
Di Campli C; Zocco MA; Saulnier N; Grieco A; Rapaccini G; Addolorato G; Rumi C; Santoliquido A; Leone G; Gasbarrini G; Gasbarrini A
Dig Liver Dis; 2007 Dec; 39(12):1071-6. PubMed ID: 17964871
[TBL] [Abstract][Full Text] [Related]
26. [Comparison of 2 strategies in the treatment of radiogenic leukopenia using granulocyte colony stimulating factor].
Adamietz IA; Rosskopf B; Dapper FD; von Lieven H; Böttcher HD
Strahlenther Onkol; 1997 Mar; 173(3):170-1. PubMed ID: 9122859
[No Abstract] [Full Text] [Related]
27. Neutropenia in an extremely premature infant treated with recombinant human granulocyte colony-stimulating factor.
Roberts RL; Szelc CM; Scates SM; Boyd MT; Soderstrom KM; Davis MW; Glaspy JA
Am J Dis Child; 1991 Jul; 145(7):808-12. PubMed ID: 1711773
[TBL] [Abstract][Full Text] [Related]
28. Granulocyte colony-stimulating factor treatment of antithyroid drug-induced granulocytopenia.
Tajiri J; Noguchi S; Okamura S; Morita M; Tamaru M; Murakami N; Niho Y
Arch Intern Med; 1993 Feb; 153(4):509-14. PubMed ID: 7679571
[TBL] [Abstract][Full Text] [Related]
29. Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry.
de la Rubia J; de Arriba F; Arbona C; Pascual MJ; Zamora C; Insunza A; Martínez D; Paniagua C; Díaz MA; Sanz MA
Haematologica; 2008 May; 93(5):735-40. PubMed ID: 18387976
[TBL] [Abstract][Full Text] [Related]
30. Colony-stimulating factor for treatment of leukopenia after kidney allografting.
Tajima A; Aso Y; Kawabe K; Suzuki K; Ohtawara Y; Ohta N; Hata M; Nakano M; Ushiyama T; Ueda D
Transplant Proc; 1991 Feb; 23(1 Pt 2):1369-70. PubMed ID: 1703338
[No Abstract] [Full Text] [Related]
31. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression.
Antman KS; Griffin JD; Elias A; Socinski MA; Ryan L; Cannistra SA; Oette D; Whitley M; Frei E; Schnipper LE
N Engl J Med; 1988 Sep; 319(10):593-8. PubMed ID: 3045544
[TBL] [Abstract][Full Text] [Related]
32. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
[TBL] [Abstract][Full Text] [Related]
33. Effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on leukocyte count and survival rate of dogs with parvoviral enteritis.
Mischke R; Barth T; Wohlsein P; Rohn K; Nolte I
Res Vet Sci; 2001 Jun; 70(3):221-5. PubMed ID: 11676617
[TBL] [Abstract][Full Text] [Related]
34. Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis.
Ziemer M; Wiesend CL; Vetter R; Weiss J; Blaschke S; Norgauer J; Mockenhaupt M
Arch Dermatol; 2007 Jun; 143(6):711-6. PubMed ID: 17576936
[TBL] [Abstract][Full Text] [Related]
35. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
36. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.
Yang Y; Xu J; Li F; Zhu X
Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409
[TBL] [Abstract][Full Text] [Related]
37. Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome.
Ghislain PD; Roujeau JC
Dermatol Online J; 2002 Jun; 8(1):5. PubMed ID: 12165215
[TBL] [Abstract][Full Text] [Related]
38. Shorter interval between cycles of cyclophosphamide, doxorubicin, cisplatin using recombinant human granulocyte colony-stimulating factor for urothelial cancer--phase I/II study.
Yoshida O; Kakehi Y; Arai Y; Tomoyoshi T; Okada Y; Matsuda T; Mikami O; Fukuyama T; Hida S; Okabe T
Int J Urol; 1995 Nov; 2(5):316-21. PubMed ID: 8749950
[TBL] [Abstract][Full Text] [Related]
39. Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia.
Ohno R; Tomonaga M; Kobayashi T; Kanamaru A; Shirakawa S; Masaoka T; Omine M; Oh H; Nomura T; Sakai Y
N Engl J Med; 1990 Sep; 323(13):871-7. PubMed ID: 1697646
[TBL] [Abstract][Full Text] [Related]
40. [Effect of timing of granulocyte-colony stimulating factor administration on leukopenia induced by systemic chemotherapy in patients with non-small-cell lung cancer--multi-center randomized crossover study].
Katakami N; Hasegawa T; Umeda B; Adachi S; Ishii N; Takada Y; Tsubota N; Nakano K; Tamura R; Nakai H
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 May; 34(5):520-8. PubMed ID: 8753109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]